Penicillin resistance and serotyping of Streptococcus pneumoniae in Latin America

Paulo Camargos1, Gilberto Bueno Fischer, Helena Mocelin

  • 1Department of Paediatrics, Medical School, Federal University of Minas Geraias, Avenida Alfredo Balena, 190/Room 4061, 30130-100 Belo Horizonte, and Respiratory Department, Hospital da Criança Santo Antonio, Porto Alegre, Brazil. pcamargs@medicina.ufmg.br

Insights

Streptococcus pneumoniae causes severe pneumonia in young children. A study found prevalent serotypes and penicillin resistance in Latin America, with limited vaccine representation.

Area of Science:

  • Pediatric infectious diseases
  • Bacteriology
  • Vaccinology

Background:

  • Streptococcus pneumoniae is a leading cause of bacterial pneumonia in children under five, particularly in developing nations.
  • High mortality rates associated with Strep. pneumoniae pneumonia necessitate effective prevention and treatment strategies.

Purpose of the Study:

  • To identify prevalent Streptococcus pneumoniae serotypes in Latin America.
  • To assess the representativity of these serotypes in current conjugated vaccines.
  • To determine the level of penicillin resistance in isolated strains.

Main Methods:

  • The Regional System for Vaccines Group (SIREVA) of the pan-American Health Organisation (PAHO) conducted a study across six Latin American countries.
  • Serotyping of Streptococcus pneumoniae isolates was performed.
  • Penicillin resistance levels were determined for the identified serotypes.

Main Results:

  • Several serotypes, including 14, 5, 1, 6A/B, 23F, 7F, 9V, 19F, 18C, 19A, and 9N, were found to be prevalent in the region.
  • Penicillin resistance varied significantly, from 2% in Brazil to 21.1% in Mexico.
  • Only 58% of the isolated serotypes were covered by the seven-valent conjugated vaccine.

Conclusions:

  • Continued surveillance of Streptococcus pneumoniae serotypes and antibiotic resistance is crucial for Latin America.
  • The current seven-valent vaccine does not fully cover the prevalent serotypes in the region.
  • Ongoing monitoring is essential to guide the selection of appropriate conjugated vaccine formulations for optimal public health impact.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...